Bristol Myers Squibb to Present at J.P. Morgan’s 40th Annual Healthcare Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Bristol Myers Squibb (NYSE: BMY) will present at J.P. Morgan’s 40th Annual Virtual Healthcare Conference on January 10, 2022. The formal presentation by Giovanni Caforio, M.D., Board Chair and CEO, is scheduled for 7:30 a.m. ET. The event will be webcast live, with related materials available beforehand. A replay and archived version will be accessible after the event. Bristol Myers Squibb is committed to discovering and delivering innovative medicines for serious diseases.
Positive
None.
Negative
None.
Insights
Analyzing...
NEW YORK--(BUSINESS WIRE)--
Bristol Myers Squibb (NYSE: BMY) today announced that the company will present at J.P. Morgan’s 40th Annual Virtual Healthcare Conference on Monday, January 10, 2022. Giovanni Caforio, M.D., Board Chair and Chief Executive Officer will make a formal presentation and answer questions about the company at 7:30 a.m. ET.
The event will be webcast simultaneously at http://investor.bms.com with materials related to the presentation available at the start of the live webcast. A replay and archived edition of the presentation will be available following the event.
About Bristol Myers Squibb
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.
An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.